News & Articles

The strategic partnership aims to catapult COVID-19 diagnostic testing capacity well ahead of the significant demand

It's comprehensive SARS-COV-2 offerings span RT-PCR, high throughput RNA extraction, automation, ELISA and lateral flow based serology testing.

New kit is designed to enable short term prediction of pre-eclampsia and aid in diagnosis in the second and third trimesters of pregnancy

Clinical laboratories certified to perform high complexity tests under Clinical Laboratory Improvement Amendments (CLIA) can immediately begin using this ELISA

These are some of the first antibody detection tests to be CE marked in Europe and available for COVID-19 testing

Clinical laboratories can immediately begin using this kit to detect SARS-CoV-2

The PaddyCheck PC 6800 platform is said to increase analysis throughput and accuracy, supporting standardized quality control for rice classification

PerkinElmer will distribute Shuwen’s diagnostic test for preeclampsia in over 100 countries

Workstations and high-content screening system automate workflows to help researchers generate invaluable insights

New kit from PerkinElmer shown to achieve over 90% correlation rate between biopsied embryos and testing spent culture media

ChLIA-based tests for detection of antibodies against Borrelia and Epstein-Barr virus now available on EUROIMMUN RA Analyzer 10 System

Perkin Elmer, Inc. launches new products to advance the management of AAV

New product’s advanced technologies enable flexible, reliable analysis of a broad range of sample types

The personal genomics product will focus on 59 genes identified by the American College of Medical Genetics and Genomics

Next-generation mass spectrometry-based solution analyzes dried blood spots from newborn babies to test for wide range of metabolic disorders

High throughput mass spectrometry-based clinical solution can run hundreds of samples per day

Pre-Term Preeclampsia Project “ASPRE” Study Utilized PerkinElmer’s DELFIA Xpress PlGF 1-2-3 Assay to Identify Women who Would Benefit from Low-Dose Aspirin

New solution facilitates advanced genomics and cancer research, drug development, and next generation sequencing

Laboratory expands access to innovative solutions for safer pregnancies and healthier babies in India

New data discovery solution leverages Attivio's platform to provide insight into complex scientific challenges